Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02231957 · ClinicalTrials.gov registry record · NA
Text Message Vaccine Reminders for Adolescents With Chronic Medical Conditions
A NA study of Vaccination, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 416
- Enrollment target
- 1
- Study location
NCT02231957: Completed NA study of Vaccination, sponsored by Columbia University.
NCT02231957 is a NA study of Vaccination that has completed, run by Columbia University. The registered enrollment target is 416 participants, below the 10,199-participant average among 12 other Vaccination trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02231957, a NA study of Vaccination, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 416 participants
- Enrollment target
- 1
- Study location
Study Summary
There are a growing number of adolescents with chronic medical conditions in the United States. The Advisory Committee on Immunization Practices (ACIP) recommends HPV vaccination and annual influenza vaccination of all adolescents. Pneumococcal polysaccharide vaccination is also recommended for certain high-risk patients. Limited studies suggest that vaccination coverage of this population remains sub-optimal. Text message vaccine reminder/recall has been shown to be effective in increasing uptake of select pediatric and adolescents vaccines, but has yet to be examined among patients with chronic medical conditions who may also face unique barriers to vaccination. This intervention aims to implement and evaluate the use of text message vaccine reminders among urban low-income minority adolescents with chronic medical conditions. This investigator-initiated study is supported in part by a grant from the Pfizer Medical Education Group.
Conditions Studied
Interventions
- OTHER educational text message reminders
- OTHER conventional text message reminders
Study Locations (1)
New York
- NewYork-Presbyterian Hospital/Columbia University Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 416 participants |
| Start Date | 2014-07 |
| Est. Completion | 2017-01 |
| Phase | NA |
What the finished NCT02231957 record still lists
NCT02231957 is an interventional study that assigns participants to a tested intervention. The registered 416 participants enrollment target is mid-sized for trials with a published cap, below the 10,199-participant average among 12 other Vaccination trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Vaccination appearing as the primary indexed condition, and to 2 interventions - of which educational text message reminders is the first listed.
NCT02231957 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02231957 about?
NCT02231957 is a clinical study titled "Text Message Vaccine Reminders for Adolescents With Chronic Medical Conditions". There are a growing number of adolescents with chronic medical conditions in the United States. The Advisory Committee on Immunization Practices (ACIP) recommends HPV vaccination and annual influenza vaccination of all adolescents. Pneumococcal polysaccharide vaccination is also recommended for cert...
What is the current status of trial NCT02231957?
This trial is currently completed. It is a NA study. The enrollment target is 416 participants. The study started on 2014-07. Estimated completion is 2017-01.
What conditions does trial NCT02231957 study?
This clinical trial studies the following conditions: Vaccination.
What interventions are being tested in trial NCT02231957?
The interventions under investigation include: educational text message reminders (OTHER), conventional text message reminders (OTHER).
Who is sponsoring clinical trial NCT02231957?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02231957 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vaccination
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02231957's enrollment target sits among peer trials
416 9th of 12 higher than 4 of 12 other Vaccination trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Vaccination trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Can Stories Encourage the Elderly to Vaccinate? Combining Viewer-tailored Personal Narrative Videos With Informational Videos to Improve Vaccine Uptake Among Older Adults
RECRUITING · NA
-
"Facts Tell… and With Stories Sell?" Combining Viewer-tailored Personal Human Papillomavirus (HPV) Narrative Video With HPV Vaccine Information Video to Improve HPV Vaccine Uptake
RECRUITING · NA
-
ARISe at UMass Chan
RECRUITING · NA
-
Kaiser Colorado Flu Nudge
ACTIVE NOT RECRUITING · NA
-
Text Message Reminder-Recalls For Early Childhood Vaccination
COMPLETED · NA
-
The STOP-HPV Trial 2: Performance Feedback Intervention
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03527537 · 416 participants · Phase 4
Gestational Diabetes and Pharmacotherapy (GAP)
- NCT05007782 · 416 participants · Phase 1
Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors
- NCT05520099 · 416 participants
Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform
- NCT06075745 · 416 participants · Phase 2
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia